COVID-19 treatment Paxlovid for high-risk adults close to full FDA approval

FILE - Doses of the anti-viral drug Paxlovid are displayed in New York, on Monday, Aug. 1, 2022. The COVID-19 medication won another vote of confidence from U.S. health advisors on Thursday, March 16, 2023, clearing the way for its full regulatory approval after being used by millions of Americans under emergency use. (AP Photo/Stephanie Nano, File)